scorecardresearch
Wednesday, September 10, 2025
TopicPharmacy of the world

Topic: Pharmacy of the world

India inspects drug factories as Gambia controversy lingers

The deaths of at least 70 children in Gambia has dented the pharmaceutical industry's image, though India says the drugs made by New Delhi-based Maiden Pharmaceuticals Ltd were not at fault.

Modi govt refreshes plan to prioritise drug discovery, will launch hunt for ‘R&D head’

Modi govt’s efforts seek to address criticism lobbed at India for failing to discover even a single drug molecule despite being the largest producer of generic medicines in the world.

Indian vaccine exports take ill as they are not immune to Chinese competition bug

Indian vaccine exports have been falling steadily since 2015-16 even as the global market has been expanding under the threat of new pandemics.

On Camera

Nepal’s unrest is a wake-up call for India’s trade

The current turmoil also points to a new dimension of trade vulnerability: digital disruption. Nepal’s MSMEs and exporters are cut off from essential communication and marketing tools.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Denmark tweaks its banned exports list, delivery of critical system for Tejas MK 1A starts 

HAL has produced 10 Tejas Mk 1A and is now awaiting further deliveries of engines from American firm GE—delayed by two and half years, so far.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?